WuXi Biologics inks lease agreement for 3rd U.S. facility in global expansion push kblankenship Tue, 06/09/2020 – 09:18

AbbVie’s Humira defense may keep prices high, but it’s still legal, judge rules esagonowsky Tue, 06/09/2020 – 09:27

Sanofi’s Sarclisa rejected by NICE over uncertainties on total benefit, cost-effectiveness esagonowsky Tue, 06/09/2020 – 11:02

Fujifilm plots $890M infusion at Danish biologics plant to double production capacity kblankenship Tue, 06/09/2020 – 13:13

Virus DNA left on a hospital bed rail was found in nearly half of all sites sampled across […]

Rice University neuroengineers have created a tiny surgical implant that can electrically stimulate the brain and nervous system […]

The study failed to meet statistical significance for the primary endpoint, however, it did show a number of […]

The research also suggests that coronavirus was more infectious than previously estimated

It is not certain how much more clinical benefit Sarclisa has over existing therapies, the Institute said

The new condition is called Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS)